Clinical Trial

Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU

Study acronym: TAVERN
Recruiting
View on ClinicalTrials.gov →
Summary
This study will demonstrate the impact of taVNS on reducing adverse events in NeuroICU patients, determine if taVNS reduces length of stay, and quantify the economic benefits of taVNS implementation in a broader neurocritical care population.
Trial Details
NCT Number NCT07219108
Lead Sponsor Washington University School of Medicine
Conditions Acute Neurological Injury, Acute Medical Conditions
Enrollment 160 participants
Start Date 2025-09-24
Primary Completion 2027-09-23 (estimated)
Study Completion 2027-09-23 (estimated)
Updated on ClinicalTrials.gov 2025-10-21